Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Merus Labs International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Merus Labs International Inc, Medical Devices Deals, 2012 to YTD 2018 10
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Merus Labs Acquires French Rights to Four Products from Sanofi for USD25 Million 12
Merus Labs International Acquires Rights for Three Cardiovascular Products in Europe and Other Markets from UCB 13
Merus Labs Acquires Rights to Salagen and Estraderm MX from Novartis Pharma for USD30 Million 14
Merus Labs Acquires Sintrom from Novartis 15
Merus Labs Completes Acquisition Of Prescription Medicine Product From Novartis 16
Merus Labs International Acquires North America Rights Of FACTIVE Tablets From Cornerstone Therapeutics 17
Partnerships 18
Merus Labs Enters into Agreement with Vansen Pharma 18
Equity Offering 19
Merus Labs Raises USD21 Million in Private Placement of Shares upon Exercise of Warrants 19
Merus Labs Raises USD20 Million in Private Placement of Subscription Receipts 21
Merus Labs Completes Partial Exercise of Underwriter’s Over Allotment Option for Public Offering of Shares for USD63 Million 22
Merus Labs Raises USD9.2 Million in Private Placement of Preferred Shares 23
Merus Labs Raises USD28.7 Million in Public Offering of Shares 24
Merus Labs International Completes Underwriters Exercise Of Full Over-Allotment Option Of Private Placement Of Shares For US$20.7 Million 25
Merus Labs Completes Private Placement Of Shares For US$4.4 Million 26
Merus Labs Announces Public Offering Of Common Shares For US$10.1 Million 27
Asset Transactions 28
Okana Ventures Acquires North American Product Rights For Factive From Merus Labs For Up to US$3.4 Million 28
Acquisition 30
Norgine Acquires Merus Labs International 30
Merus Labs International Inc – Key Competitors 32
Merus Labs International Inc – Key Employees 33
Merus Labs International Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
May 11, 2017: Merus Labs Reports Fiscal Q2 2017 Results 35
Feb 14, 2017: Merus Labs Reports Fiscal Q1 2017 Results 37
Other Significant Developments 40
May 04, 2017: Merus Labs Announces Key Milestone for Sintrom Profit Enhancing Initiative 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
Merus Labs International Inc, Pharmaceuticals & Healthcare, Key Facts 2
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Merus Labs International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Merus Labs International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Merus Labs International Inc, Medical Devices Deals, 2012 to YTD 2018 10
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Merus Labs Acquires French Rights to Four Products from Sanofi for USD25 Million 12
Merus Labs International Acquires Rights for Three Cardiovascular Products in Europe and Other Markets from UCB 13
Merus Labs Acquires Rights to Salagen and Estraderm MX from Novartis Pharma for USD30 Million 14
Merus Labs Acquires Sintrom from Novartis 15
Merus Labs Completes Acquisition Of Prescription Medicine Product From Novartis 16
Merus Labs International Acquires North America Rights Of FACTIVE Tablets From Cornerstone Therapeutics 17
Merus Labs Enters into Agreement with Vansen Pharma 18
Merus Labs Raises USD21 Million in Private Placement of Shares upon Exercise of Warrants 19
Merus Labs Raises USD20 Million in Private Placement of Subscription Receipts 21
Merus Labs Completes Partial Exercise of Underwriter's Over Allotment Option for Public Offering of Shares for USD63 Million 22
Merus Labs Raises USD9.2 Million in Private Placement of Preferred Shares 23
Merus Labs Raises USD28.7 Million in Public Offering of Shares 24
Merus Labs International Completes Underwriters Exercise Of Full Over-Allotment Option Of Private Placement Of Shares For US$20.7 Million 25
Merus Labs Completes Private Placement Of Shares For US$4.4 Million 26
Merus Labs Announces Public Offering Of Common Shares For US$10.1 Million 27
Okana Ventures Acquires North American Product Rights For Factive From Merus Labs For Up to US$3.4 Million 28
Norgine Acquires Merus Labs International 30
Merus Labs International Inc, Key Competitors 32
Merus Labs International Inc, Key Employees 33
Merus Labs International Inc, Subsidiaries 34
List of Figures
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Merus Labs International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Merus Labs International Inc, Medical Devices Deals, 2012 to YTD 2018 10